Genes down-regulated by GC treatment
| Gene symbol . | Description (NCBI Gene) . | N-fold . | P . |
|---|---|---|---|
| T-cell chemotaxis | |||
| CXCL11* | Chemokine (C-X-C motif) ligand 11 | −4.9 | .017 |
| CXCL10* | Chemokine (C-X-C motif) ligand 10 | −3.3 | .017 |
| CCL5 | Chemokine (C-C motif) ligand 5 | −2.5 | .016 |
| CXCL9* | Chemokine (C-X-C motif) ligand 9 | −2.0 | .030 |
| Adhesion | |||
| FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | −2.5 | .021 |
| ITGAL | Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | −2.5 | .029 |
| CD36 | CD36 antigen (collagen type I receptor, thrombospondin receptor) | −2.2 | .017 |
| LST1* | Leukocyte specific transcript 1 | −2.0 | .009 |
| OLR1 | Oxidized low density lipoprotein (lectin-like) receptor 1 | −2.0 | .017 |
| Apoptosis | |||
| STAT1* | Signal transducer and activator of transcription 1, 91 kDa | −3.4 | .023 |
| DNASE1L3 | Deoxyribonuclease I-like 3 | −2.6 | .019 |
| TNFSF10 | Tumor necrosis factor (ligand) superfamily, member 10 | −2.2 | .038 |
| PEA15 | Phosphoprotein enriched in astrocytes 15 (antiapoptosis) | −2.1 | .005 |
| CST7 | Cystatin F (leukocystatin) | −2.1† | .029 |
| Oxidative functions | |||
| PTGS1 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | −2.9 | .006 |
| SCO2 | SCO cytochrome oxidase deficient homolog 2 (yeast) | −2.4 | .018 |
| CYBB | Cytochrome b-245, beta polypeptide (chronic granulomatous disease), component NAPDH oxidase | −2.0 | .023 |
| Genes up-regulated by IFNγ | |||
| GBP1* | Guanylate binding protein 1, interferon-inducible, 67 kDa | −2.6 | .012 |
| IFITM1* | Interferon induced transmembrane protein 1 (9–27) | −2.1 | .040 |
| WARS* | Tryptophanyl-tRNA synthetase | −2.1 | .017 |
| Gene symbol . | Description (NCBI Gene) . | N-fold . | P . |
|---|---|---|---|
| T-cell chemotaxis | |||
| CXCL11* | Chemokine (C-X-C motif) ligand 11 | −4.9 | .017 |
| CXCL10* | Chemokine (C-X-C motif) ligand 10 | −3.3 | .017 |
| CCL5 | Chemokine (C-C motif) ligand 5 | −2.5 | .016 |
| CXCL9* | Chemokine (C-X-C motif) ligand 9 | −2.0 | .030 |
| Adhesion | |||
| FCN1 | Ficolin (collagen/fibrinogen domain containing) 1 | −2.5 | .021 |
| ITGAL | Integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | −2.5 | .029 |
| CD36 | CD36 antigen (collagen type I receptor, thrombospondin receptor) | −2.2 | .017 |
| LST1* | Leukocyte specific transcript 1 | −2.0 | .009 |
| OLR1 | Oxidized low density lipoprotein (lectin-like) receptor 1 | −2.0 | .017 |
| Apoptosis | |||
| STAT1* | Signal transducer and activator of transcription 1, 91 kDa | −3.4 | .023 |
| DNASE1L3 | Deoxyribonuclease I-like 3 | −2.6 | .019 |
| TNFSF10 | Tumor necrosis factor (ligand) superfamily, member 10 | −2.2 | .038 |
| PEA15 | Phosphoprotein enriched in astrocytes 15 (antiapoptosis) | −2.1 | .005 |
| CST7 | Cystatin F (leukocystatin) | −2.1† | .029 |
| Oxidative functions | |||
| PTGS1 | Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) | −2.9 | .006 |
| SCO2 | SCO cytochrome oxidase deficient homolog 2 (yeast) | −2.4 | .018 |
| CYBB | Cytochrome b-245, beta polypeptide (chronic granulomatous disease), component NAPDH oxidase | −2.0 | .023 |
| Genes up-regulated by IFNγ | |||
| GBP1* | Guanylate binding protein 1, interferon-inducible, 67 kDa | −2.6 | .012 |
| IFITM1* | Interferon induced transmembrane protein 1 (9–27) | −2.1 | .040 |
| WARS* | Tryptophanyl-tRNA synthetase | −2.1 | .017 |